Microgreens on Sleep (GREENSLEEP)

April 12, 2026 updated by: DAMLA AYKORA, Çanakkale Onsekiz Mart University

Microgreen Consumption and Effects on Sleep Architecture

This study aims to investigate the effects of Microgreen use on sleep architecture in athletes. Sleep architecture refers to the structural organization of sleep, including the distribution of non-rapid eye movement (NREM) and rapid eye movement (REM) sleep stages, sleep onset latency, total sleep time, and sleep efficiency. In athletic populations, optimal sleep is essential for recovery, hormonal regulation, cognitive performance, and physical adaptation.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Çanakkale
      • Çanakkale, Çanakkale, Turkey (Türkiye), 17100
        • Canakkale Onsekiz Mart University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • active athlete

Exclusion Criteria:

  • with no cardiovascular disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: control
only cabbage received
cabbage was orally given to control
Experimental: microgreen
microgreen coctail received
microgreen group received orally microgreen coctail

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DOMS
Time Frame: From the end of treatment at 3 weeks
Fit bitcharge measurements and BORG scale
From the end of treatment at 3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • M Bhaswant

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 10, 2025

Primary Completion (Actual)

February 14, 2026

Study Completion (Actual)

March 4, 2026

Study Registration Dates

First Submitted

March 5, 2026

First Submitted That Met QC Criteria

April 12, 2026

First Posted (Actual)

April 17, 2026

Study Record Updates

Last Update Posted (Actual)

April 17, 2026

Last Update Submitted That Met QC Criteria

April 12, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Architecture

Clinical Trials on cabbage for control

Subscribe